Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.
Robert W. Rand(Saint John's Health Center), Raj K. Puri(Integrated BioTherapeutics (United States)), Robert J. Kreitman(National Cancer Institute), Ira Pastan(National Institutes of Health), Frederick Varricchio(Rutgers, The State University of New Jersey), N Patronas(United States Army Medical Research and Development Command)
PubMed
June 1, 2000
Cited by 226
Related Papers
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
|Nature Biotechnology|2006|2.2k
The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies
|BMC Bioinformatics|2008|404
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System
|The Pediatric Infectious Disease Journal|2004|381
α-Galactosidase A deficient mice: A model of Fabry disease
|Proceedings of the National Academy of Sciences|1997|370